The DOI matches its Crossref record; 385 of the 385 references it cites were found in a registry or an index.
Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives
Open accessAbstract
Ocular diseases seriously affect patients' vision and life quality, with a global morbidity of over 43 million blindness. However, efficient drug delivery to treat ocular diseases, particularly intraocular disorders, remains a huge challenge due to multiple ocular barriers that significantly affect the ultimate therapeutic efficacy of drugs. Recent advances in nanocarrier technology offer a promising opportunity to overcome these barriers by providing enhanced penetration, increased retention, improved solubility, reduced toxicity, prolonged release, and targeted delivery of the loaded drug to the eyes. This review primarily provides an overview of the progress and contemporary applications of nanocarriers, mainly polymer- and lipid-based nanocarriers, in treating various eye diseases, highlighting their value in achieving efficient ocular drug delivery. Additionally, the review covers the ocular barriers and administration routes, as well as the prospective future developments and challenges in the field of nanocarriers for treating ocular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–385 of 385
El‐Rehim, H. A. A., Swilem, A. E., Klingner, A., Hegazy, E. A., & Hamed, A. A. (2013) · Biomacromolecules · doi:10.1021/bm301742m · Cited by 84
Lou, X., Hu, Y., Zhang, H., Liu, J., & Zhao, Y. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01199-3 · Cited by 83
Effect of steroids and nonsteroidal antiinflammatory agents on human ocular fibroblast.
Nguyen, K. D., & Lee, D. A. (1992) · PubMed · Cited by 82
Management of bacterial postoperative endophthalmitis and the role of vitrectomy
Clarke, B., Williamson, T. H., Gini, G., & Gupta, B. (2018) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2018.02.003 · Cited by 82
Mahaling, B., Srinivasarao, D. A., Ganugula, R., Kasam, R. K., Reddy, G. B., & Katti, D. S. (2018) · Nanoscale · doi:10.1039/c8nr00058a · Cited by 82
Luo, L., Yang, J., Oh, Y., Hartsock, M. J., Xia, S., Kim, Y.-C., Ding, Z., Meng, T., Eberhart, C. G., Ensign, L. M., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.018 · Cited by 81
Hove, I. V., Hu, T., Beets, K., Bergen, T. V., Etienne, I., Stitt, A. W., Vermassen, E., & Feyen, J. H. M. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100966 · Cited by 81
Radwan, S. E.-S., El-Kamel, A. H., Zaki, E. I., Burgalassi, S., Zucchetti, E., & El‐Moslemany, R. M. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s316564 · Cited by 81
An Infrared Dye–Conjugated Virus-like Particle for the Treatment of Primary Uveal Melanoma
Kines, R. C., Varsavsky, I., Choudhary, S., Bhattacharya, D., Spring, S. M., McLaughlin, R., Kang, S. J., Grossniklaus, H. E., Vavvas, D. G., Monks, S., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0953 · Cited by 80
Zhang, X., Sun, J., Yao, J., Shan, K. Y., Liu, B.-H., Yao, M.-D., Ge, H., Jiang, Q. L., Zhao, C., & Yan, B. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.092 · Cited by 80
Motiejūnaitė, R., & Kazlauskas, A. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.10.013 · Cited by 79
Gene delivery nanoparticles to modulate angiogenesis
Kim, J., Mirando, A. C., Popel, A. S., & Green, J. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.11.003 · Cited by 79
Drug Transport by the Blood–Aqueous Humor Barrier of the Eye
Lee, J., & Pelis, R. M. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.069369 · Cited by 78
Oh, E. J., Choi, J.-S., Kim, H., Joo, C.-K., & Hahn, S. K. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.003 · Cited by 77
Hagigit, T., Abdulrazik, M., Valamanesh, F., Béhar‐Cohen, F., & Benita, S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.022 · Cited by 77
Buosi, F. S., Alaimo, A., Santo, M. C. D., Elı́as, F., Liñares, G. G., Acebedo, S. L., Cataña, M. A. C., Spagnuolo, C. C., Lizárraga, L., Martínez, K. D., et al. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.09.234 · Cited by 76
Francia, S., Shmal, D., Marco, S. D., Chiaravalli, G., Maya‐Vetencourt, J. F., Mantero, G., Michetti, C., Cupini, S., Manfredi, G., DiFrancesco, M. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31368-3 · Cited by 76
Afarid, M., Mahmoodi, S., & Baghban, R. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01567-7 · Cited by 76
Kim, S. H., Csaky, K. G., Wang, N. S., & Lutz, R. J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9408-z · Cited by 75
Sustained delivery of a HIF-1 antagonist for ocular neovascularization
Iwase, T., Fu, J., Yoshida, T., Muramatsu, D., Miki, A., Hashida, N., Lu, L., Oveson, B. C., Silva, R. L. E., Seidel, C. P., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.008 · Cited by 75
Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update
Lin, F.-L., Wang, P.-Y., Chuang, Y.-F., Wang, J.-H., Wong, V. H. Y., Bui, B. V., & Liu, G.-S. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.06.029 · Cited by 74
Suen, W.-L. L., & Chau, Y. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.004 · Cited by 74
Ren, T., Lin, X., Zhang, Q., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00516 · Cited by 74
Zhao, L., Chen, G., Li, J., Fu, Y., Mavlyutov, T. A., Yao, A., Nickells, R. W., Gong, S., & Guo, L. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.038 · Cited by 73
Nemr, A. A., El-Mahrouk, G. M., & Badie, H. A. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2100513 · Cited by 73
Balguri, S. P., Adelli, G. R., Janga, K. Y., Bhagav, P., & Majumdar, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.042 · Cited by 72
Hathout, R. M., Gad, H. A., Abdel-Hafez, S. M., Nasser, N., Mahdy, N. K., Ateyya, T., Amr, A., Yasser, N., Nasr, S., & Metwally, A. A. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.12.015 · Cited by 72
Latanoprost-loaded phytantriol cubosomes for the treatment of glaucoma
Bessone, C. D. V., Akhlaghi, S. P., Tártara, L. I., Quinteros, D. A., Loh, W., & Allemandi, D. A. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105748 · Cited by 72
Nguyen, D. D., Luo, L., & Lai, J. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.04.055 · Cited by 71
Insight on updates in polysaccharides for ocular drug delivery
Chandra, N. S., Gorantla, S., Priya, S., & Singhvi, G. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.120014 · Cited by 71
Ocular Pharmacokinetics of a Novel Loteprednol Etabonate 0.4% Ophthalmic Formulation
Schopf, L. R., Enlow, E., Popov, A., Bourassa, J. L., & Chen, H. (2014) · Ophthalmology and Therapy · doi:10.1007/s40123-014-0021-z · Cited by 70
Exploring Optic Nerve Axon Regeneration
Li, H., Sun, Z.-L., Yang, X., Zhu, L., & Feng, D. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666161227150250 · Cited by 70
Drug delivery to the lens for the management of cataracts
Thrimawithana, T. R., Rupenthal, I. D., Raesch, S. S., Lim, J. C.-H., Morton, J. D., & Bunt, C. R. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.03.009 · Cited by 69
Pandit, J., Sultana, Y., & Aqil, M. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118217 · Cited by 69
Kambhampati, S. P., Bhutto, I. A., Wu, T., Ho, K., McLeod, D. S., Lutty, G. A., & Kannan, R. M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.035 · Cited by 69
Protein delivery to the back of the eye: barriers, carriers and stability of anti-VEGF proteins
Radhakrishnan, K., Nirmal, S., Moreno, M. R., Nirmal, J., Fernandez, A. A., Venkatraman, S. S., & Agrawal, R. V. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.10.015 · Cited by 68
Li, Q., Lai, K. L., Chan, P. S., Leung, S. C., Li, H. Y., Fang, Y., To, K. K. W., Choi, C. H. J., Gao, Q. Y., & Lee, T. W. Y. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.12.053 · Cited by 67
Gade, S., Patel, K. K., Gupta, C. R., Anjum, M. M., Deepika, D., Agrawal, A. K., & Singh, S. K. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.04.005 · Cited by 67
Microgels and Nanogels for the Delivery of Poorly Water-Soluble Drugs
Dave, R., Randhawa, G., Kim, D., Simpson, M. J., & Hoare, T. R. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00967 · Cited by 67
Lee, T. W.-Y., & Robinson, J. R. (2001) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/10807680152729257 · Cited by 66
Controlled release of anti-VEGF by redox-responsive polydopamine nanoparticles
Jiang, P., Choi, A., & Swindle‐Reilly, K. E. (2020) · Nanoscale · doi:10.1039/d0nr03710a · Cited by 66
Tacrolimus Loaded Cationic Liposomes for Dry Eye Treatment
Chen, X., Wu, J., Lin, X., Wu, X., Yu, X., Wang, B., & Xu, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.838168 · Cited by 66
Liu, J., Zhang, X., Li, G., Xu, F., Li, S., Teng, L., Li, Y., & Sun, F. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s217038 · Cited by 65
Self-citationSteroid-Eluting Contact Lenses for Corneal and Intraocular InflammationPreprint
Bengani, L. C., Kobashi, H., Ross, A. E., Zhai, H., Salvador‐Culla, B., Tulsan, R., Kolovou, P. E., Mittal, S. K., Chauhan, S. K., Kohane, D. S., et al. (2020) · SSRN Electronic Journal · doi:10.1016/j.actbio.2020.08.013 · Cited by 65
Nanoparticle-Mediated Delivery of shRNA.VEGF-A Plasmids Regresses Corneal Neovascularization
Qazi, Y., Stagg, B. C., Singh, N., Singh, S. R., Zhang, X., Luo, L., Simonis, J. M., Kompella, U. B., & Ambati, B. K. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-9139 · Cited by 64
Cyclosporine-loaded micelles for ocular delivery: investigating the penetration mechanisms
Ghezzi, M., Ferraboschi, I., Delledonne, A., Pescina, S., Padula, C., Santi, P., Sissa, C., Terenziani, F., & Nicoli, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.07.019 · Cited by 63
Intracameral Delivery of Layer‐by‐Layer Coated siRNA Nanoparticles for Glaucoma Therapy
Dillinger, A. E., Guter, M., Froemel, F., Weber, G. R., Perkumas, K. M., Stamer, W. D., Ohlmann, A., Fuchshofer, R., & Breunig, M. (2018) · Small · doi:10.1002/smll.201803239 · Cited by 63
Jain, N., Verma, A. K., & Jain, N. K. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1775726 · Cited by 62
Chen, Y.-S., Green, C. R., Wang, K., Danesh-Meyer, H. V., & Rupenthal, I. D. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.005 · Cited by 61
Antimicrobial nanomedicine for ocular bacterial and fungal infection
Fan, W., Han, H., Chen, Y., Zhang, X., Gao, Y., Li, S., Jin, Q., Ji, J., & Yao, K. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00966-x · Cited by 61
Self-citationAbd-Elsalam, W. H., & ElKasabgy, N. A. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.070 · Cited by 59
Toragall, V. B., & Baskaran, V. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117409 · Cited by 59
Chang, C.-Y., Wang, M.-C., Miyagawa, T., Chen, Z.-Y., Lin, F., Chen, K.-H., Liu, G., & Tseng, C. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s114754 · Cited by 58
Jiang, P., Chaparro, F. J., Cuddington, C. T., Palmer, A. F., Ohr, M. P., Lannutti, J. J., & Swindle‐Reilly, K. E. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.036 · Cited by 58
Zhou, X., Lv, J., Li, G., Qian, T., Jiang, H., Xu, J., Cheng, Y., & Hong, J. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120600 · Cited by 58
Self-citationNon-viral Gene Therapy for Stargardt Disease with ECO/pRHO-ABCA4 Self-Assembled Nanoparticles
Sun, D., Schur, R. M., Sears, A. E., Gao, S., Vaidya, A. M., Sun, W., Maeda, A., Kern, T. S., Palczewski, K., & Lu, Z. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.09.010 · Cited by 57
Micelle-solubilized axitinib for ocular administration in anti-neovascularization
Shi, S., Peng, F., Zheng, Q., Zeng, L., Chen, H., Li, X., & Huang, J. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.051 · Cited by 56
Cyclodextrin–Amphiphilic Copolymer Supramolecular Assemblies for the Ocular Delivery of Natamycin
Lorenzo-Veiga, B., Sigurðsson, H. H., Loftsson, Þ., & Alvarez‐Lorenzo, C. (2019) · Nanomaterials · doi:10.3390/nano9050745 · Cited by 56
Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma
Chai, P., Jia, R., Li, Y., Zhou, C., Gu, X., Yang, L., Shi, H., Tian, H., Lin, H., Yu, J., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101030 · Cited by 56
The suprachoroidal pathway: a new drug delivery route to the back of the eye
Do, U., Young, S. A., Thrimawithana, T. R., Abdelkader, H., Alani, A. W. G., Pierscionek, B. K., & Alany, R. G. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.010 · Cited by 55
Kim, H., Choi, J., Kim, K. S., Yang, J., Joo, C., & Hahn, S. K. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.07.016 · Cited by 55
Ohigashi, H., Hashimoto, D., Hayase, E., Takahashi, S., Ara, T., Yamakawa, T., Sugita, J., Onozawa, M., Nakagawa, M., & Teshima, T. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018028431 · Cited by 54
Parikh, B. H., Liu, Z., Blakeley, P., Lin, Q., Singh, M., Ong, J. Y., Ho, K. H., Lai, J. W., Bogireddi, H., Tran, K. C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30474-6 · Cited by 54
Han, H., Yin, Q., Tang, X., Yu, X., Gao, Q., Tang, Y., Grzybowski, A., Yao, K., Ji, J., & Shentu, X. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00874e · Cited by 53
Self-citationCurcumin nanoparticles inhibit corneal neovascularization
Pradhan, N., Guha, R., Chowdhury, S., Nandi, S., Konar, A., & Hazra, S. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1277-z · Cited by 53
Shen, H., Chan, E. C., Lee, J. H., Bee, Y., Lin, T., Dusting, G. J., & Liu, G. (2015) · Nanomedicine · doi:10.2217/nnm.15.47 · Cited by 53
High-density lipoprotein mutant eye drops for the treatment of posterior eye diseases
Suda, K., Murakami, T., Gotoh, N., Fukuda, R., Hashida, Y., Hashida, M., Tsujikawa, A., & Yoshimura, N. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.036 · Cited by 53
Zhou, Y., Li, L., Li, S., Li, S., Zhao, M., Zhou, Q., Gong, X., Yang, J., & Chang, J. K. (2019) · Nanoscale · doi:10.1039/c9nr02350j · Cited by 53
Self-citationNarvekar, P., Bhatt, P., Fnu, G., & Sutariya, V. B. (2019) · Assay and Drug Development Technologies · doi:10.1089/adt.2019.920 · Cited by 53
Rebibo, L., Tam, C. K. P., Sun, Y., Shoshani, E., Badihi, A., Nassar, T., & Benita, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.035 · Cited by 53
Zhang, X., Lai, K., Li, S., Wang, J., Li, J., Wang, W., Ni, S., Lu, B., Grzybowski, A. E., Ji, J., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.07.015 · Cited by 53
Self-citationChaharband, F., Daftarian, N., Kanavi, M. R., Varshochian, R., Hajiramezanali, M., Norouzi, P., Arefian, E., Atyabi, F., & Dinarvand, R. (2020) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2020.102181 · Cited by 52
Nanoparticle-mediated gene transfer specific to retinal pigment epithelial cells
Koirala, A., Makkia, R. S., Cooper, M. J., & Naash, M. I. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.062 · Cited by 51
Hackett, S. F., Fu, J., Kim, Y. C., Tsujinaka, H., Shen, J., Silva, R. L. E., Khan, M., Hafiz, Z., Wang, T., Shin, M. D., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119935 · Cited by 51
Zhang, C., Wang, Y.-S., Wu, H., Zhang, Z.-X., Cai, Y., Hou, H.-Y., Zhao, W., Yang, X.-M., & Ma, J.-X. (2009) · Gene Therapy · doi:10.1038/gt.2009.158 · Cited by 50
Novel Nano-Liposome Formulation for Dry Eyes with Components Similar to the Preocular Tear Film
Vicario‐de‐la‐Torre, M., Caballo-González, M., Vico, E., Morales‐Fernández, L., Arriola‐Villalobos, P., Heras, B. D. L., Benitez-del-Castillo, J. M., Guzmán, M., Millar, T., Herrero‐Vanrell, R., et al. (2018) · Polymers · doi:10.3390/polym10040425 · Cited by 50
Suri, R., Neupane, Y. R., Mehra, N., Nematullah, M., Khan, F., Alam, O., Iqubal, A., Jain, G. K., & Kohli, K. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.09.069 · Cited by 50
Nanoparticle-mediated miR200-b delivery for the treatment of diabetic retinopathy
Mitra, R. N., Nichols, C. A., Guo, J., Makkia, R. S., Cooper, M. J., Naash, M. I., & Han, Z. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.020 · Cited by 49
Lin, H. Z., Liu, Y., Kambhampati, S. P., Hsu, C., Kannan, R. M., & Yiu, S. C. (2018) · The Ocular Surface · doi:10.1016/j.jtos.2018.05.004 · Cited by 49
Liu, J., Li, S., Li, G., Li, X., Yu, C., Fu, Z., Li, X., Teng, L., Li, Y., & Sun, F. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.04.012 · Cited by 49
Self-citationA Long-Acting Curcumin Nanoparticle/In Situ Hydrogel Composite for the Treatment of Uveal Melanoma
Xie, L., Yue, W., Ibrahim, K., & Shen, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091335 · Cited by 48
Narayana, R. V. L., Jana, P., Tomar, N. R., Prabhu, V., Nair, R. M., Manukonda, R., Kaliki, S., Coupland, S. E., Alexander, J. L., Kalirai, H., et al. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.14.13 · Cited by 48
Liang, Z. C., Zhang, Z., Yang, J., Lu, P., Zhou, T., Li, J., & Zhang, J. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s340068 · Cited by 48
Self-citationSun, D., Sahu, B., Gao, S., Schur, R. M., Vaidya, A. M., Maeda, A., Palczewski, K., & Lu, Z.-R. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2017.02.005 · Cited by 47
Lee, J., Goh, U., Lee, H. J., Kim, J., Jeong, M., & Park, J. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00864 · Cited by 47
Li, M., Bian, X., Chen, X., Fan, N., Zou, H., Bao, Y., & Zhou, Y. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2032876 · Cited by 47
Penetrating-peptide-mediated non-invasive Axitinib delivery for anti-neovascularisation
Huang, Y., Zhu, Y., Cai, D., Guo, Q., Wang, J., Lei, L., Li, X., & Shi, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.009 · Cited by 46
Fan, W., Han, H., Lu, Z., Huang, Y., Zhang, Y., Chen, Y., Zhang, X., Ji, J., & Yao, K. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10380 · Cited by 46
Self-citationBisht, R., Jaiswal, J. K., Chen, Y.-S., Jin, J., & Rupenthal, I. D. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1163334 · Cited by 45
Shim, W., Kim, C. E., Lee, M., Hyeon, L. S., Park, J., Do, M., Yang, J. W., & Lee, H. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.016 · Cited by 45
Khallaf, A. M., El‐Moslemany, R. M., Ahmed, M. F., Morsi, M. H., & Khalafallah, N. M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s342975 · Cited by 45
Dendrimer as a momentous tool in tissue engineering and regenerative medicine
Shaikh, A., Kesharwani, P., & Gajbhiye, V. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.04.008 · Cited by 45
Bongiovì, F., Fiorica, C., Palumbo, F. S., Di Prima, G., Giammona, G., & Pitarresi, G. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00620 · Cited by 44
Wang, B., Tang, Y.-T., Oh, Y., Lamb, N. W., Xia, S., Ding, Z., Chen, B., Suarez, M. J., Meng, T., Kulkarni, V. R., et al. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.01.001 · Cited by 44
Li, T., Wang, Y., Chen, J., Gao, X., Pan, S., Su, Y., & Zhou, X. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1731861 · Cited by 44
Laddha, U. D., & Kshirsagar, S. J. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04589 · Cited by 44
Multifunctional Polymeric Nanoparticles for Chemo/Phototheranostics of Retinoblastoma
Mudigunda, S. V., Pemmaraju, D. B., Paradkar, S., Puppala, E. R., Gawali, B., Upadhyayula, S. M., Naidu, V. G. M., & Rengan, A. K. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c01234 · Cited by 44
Zahir‐Jouzdani, F., Mahbod, M., Soleimani, M., Vakhshiteh, F., Arefian, E., Shahhoseini, S., Dinarvand, R., & Atyabi, F. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.09.062 · Cited by 43
Jia, F., Li, L., Fang, Y., Song, M., Man, J., Jin, Q., Lei, Y., & Ji, J. (2020) · ACS Nano · doi:10.1021/acsnano.0c05977 · Cited by 42
Self-citationEfficacy of topotecan nanoparticles for intravitreal chemotherapy of retinoblastoma
Delrish, E., Jabbarvand, M., Ghassemi, F., Amoli, F. A., Atyabi, F., Lashay, A., Soleimani, M., Aghajanpour, L., & Dinarvand, R. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2020.108423 · Cited by 41
Condition responsive nanoparticles for managing infection and inflammation in keratitis
Saad, M. A., & Rao, C. M. (2017) · Nanoscale · doi:10.1039/c7nr00922d · Cited by 40
Hybrid Lipid Polymer Nanoparticles for Combined Chemo- and Photodynamic Therapy
N’diaye, M., Vergnaud, J., Nicolas, V., Faure, V., Denis, S., Abreu, S., Chaminade, P., & Rosilio, V. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00797 · Cited by 40
Self-assembling tacrolimus nanomicelles for retinal drug delivery
Gote, V., Mandal, A., Alshamrani, M., & Pal, D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111072 · Cited by 39
Cho, Y. K., Uehara, H., Young, J. R., Tyagi, P., Kompella, U. B., Zhang, X., Luo, L., Singh, N., Archer, B. J., & Ambati, B. K. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8393 · Cited by 39
Lee, H., Shim, W., Kim, C. E., Choi, S. Y., Lee, H., & Yang, J. W. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20843 · Cited by 39
Lancina, M. G., Wang, J., Williamson, G. S., & Yang, H. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00401 · Cited by 39
Li, K., Li, R., Zou, P., Li, L., Wang, H., Kong, D., Zheng, G., & Li, L. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121361 · Cited by 39
Nanoparticle-Mediated Expression of a Wnt Pathway Inhibitor Ameliorates Ocular Neovascularization
Wang, Z., Cheng, R., Lee, K., Tyagi, P., Ding, L., Kompella, U. B., Chen, J., Xu, X., & Ma, J.-X. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.304627 · Cited by 38
Review of Azithromycin Ophthalmic 1% Solution (AzaSite®) for the Treatment of Ocular Infections
Opitz, D. L., & Harthan, J. (2012) · Ophthalmology and Eye Diseases · doi:10.4137/oed.s7791 · Cited by 38
Josyula, A., Omiadze, R., Parikh, K. S., Kanvinde, P. P., Appell, M. B., Patel, P. A., Saeed, H. K., Sutar, Y. B., Anders, N. M., He, P., et al. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10238 · Cited by 38
Stack, T., Vincent, M., Vahabikashi, A., Li, G., Perkumas, K. M., Stamer, W. D., Johnson, M., & Scott, E. (2020) · Small · doi:10.1002/smll.202004205 · Cited by 37
Zuluaga, M.-F., Mailhos, C., Robinson, G. S., Shima, D. T., Gurny, R., & Lange, N. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1224 · Cited by 37
Sha, X., Chan, L., Fan, X., Guo, P., Chen, T., Liu, L., & Zhong, J. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s332127 · Cited by 37
Wu, X., Yu, G.-P., Luo, C., Maeda, A., Zhang, N., Sun, D., Zhou, Z., Puntel, A., Palczewski, K., & Lu, Z. (2013) · ACS Nano · doi:10.1021/nn4054107 · Cited by 36
Aflibercept Nanoformulation Inhibits VEGF Expression in Ocular In Vitro Model: A Preliminary Report
Kelly, S. J., Hirani, A., Shahidadpury, V., Solanki, A., Halasz, K., Gupta, S. V., Madow, B., & Sutariya, V. B. (2018) · Biomedicines · doi:10.3390/biomedicines6030092 · Cited by 36
Amphiphilic Polypeptides for VEGF siRNA Delivery into Retinal Epithelial Cells
Osipova, O., Sharoyko, V. V., Zashikhina, N., Захарова, Н. В., Tennikova, T. B., Urtti, A. O., & Korzhikova‐Vlakh, E. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12010039 · Cited by 36
Shen, Y., Yu, Y., Chaurasiya, B., Li, X., Xu, Y., Webster, T., Tu, J., & Sun, R. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s173691 · Cited by 35
Liu, A., Liang, C., Liu, J., Huang, Y., Wang, M., & Wang, L. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c23412 · Cited by 35
Hillenkamp, J., Hussain, A. A., Jackson, T. L., Cunningham, J. R., & Marshall, J. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0919 · Cited by 34
Li, T., Hou, X., Deng, H. X., Zhao, J., Huang, N., Zeng, J., Chen, H., & Gu, Y. (2015) · Photochemical & Photobiological Sciences · doi:10.1039/c4pp00412d · Cited by 34
Eriksen, A. Z., Eliasen, R., Oswald, J., Kempen, P. J., Melander, F., Andresen, T. L., Young, M. J., Baranov, P. Y., & Urquhart, A. J. (2018) · ACS Nano · doi:10.1021/acsnano.8b00596 · Cited by 34
A core-shell nanoplatform as a nonviral vector for targeted delivery of genes to the retina
Tan, G., Liu, D., Zhu, R., Pan, H., Li, J., & Pan, W. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.07.053 · Cited by 34
Kim, K. E., Jang, I., Moon, H., Kim, K. G., Jeoung, J. W., Park, K. H., & Kim, H. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16538 · Cited by 33
Lee, T. W.-Y., & Robinson, J. R. (2004) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/108076804772745455 · Cited by 33
Micali, A. G., Pisani, A., Puzzolo, D., Nowińska, A., Wylęgała, E., Teper, S. J., Wróblewska‐Czajka, E., Roszkowska, A. M., Orzechowska-Wylęgała, B., & Aragona, P. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.12.012 · Cited by 33
Celastrol-based nanomedicine promotes corneal allograft survival
Li, Z., Liu, R., Guo, Z., Chu, D., Zhu, L., Zhang, J., Shuai, X., & Li, J. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01079-w · Cited by 33
Iontophoretic ocular delivery of latanoprost-loaded nanoparticles via skin-attached electrodes
Kim, S., Min, C. H., Kim, Y. K., Ha, A., Park, C. G., Lee, S. H., Park, K. H., & Choy, Y. B. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.03.015 · Cited by 33
Zahir‐Jouzdani, F., Soleimani, M., Mahbod, M., Mottaghitalab, F., Vakhshiteh, F., Arefian, E., Shahhoseini, S., Dinarvand, R., & Atyabi, F. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-0546-0 · Cited by 32
Gene Transfer Using Micellar Nanovectors Inhibits Corneal Neovascularization In Vivo
Iriyama, A., Usui, T., Yanagi, Y., Amano, S., Oba, M., Miyata, K., Nishiyama, N., & Kataoka, K. (2011) · Cornea · doi:10.1097/ico.0b013e318206c893 · Cited by 31
Mitra, R. N., Zheng, M., Weiss, E. R., & Han, Z. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.12.004 · Cited by 31
Zahir‐Jouzdani, F., Khonsari, F., Soleimani, M., Mahbod, M., Arefian, E., Heydari, M., Shahhosseini, S., Dinarvand, R., & Atyabi, F. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27243 · Cited by 31
Dasatinib loaded nanostructured lipid carriers for effective treatment of corneal neovascularization
Li, Q., Yang, X., Zhang, P., Mo, F., Si, P., Kang, X., Wang, M., & Zhang, J. (2021) · Biomaterials Science · doi:10.1039/d0bm01599g · Cited by 30
Zhang, Y., Li, G., Zhang, X., & Lin, L. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00667g · Cited by 29
Zhang, Y., Yu, Y., Li, G., Zhang, X., Wu, Z., & Lin, L. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00229e · Cited by 29
Sorafenib Repurposing for Ophthalmic Delivery by Lipid Nanoparticles: A Preliminary Study
Bonaccorso, A., Pepe, V., Zappulla, C., Cimino, C., Pricoco, A., Puglisi, G., Giuliano, F., Pignatello, R., & Carbone, C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111956 · Cited by 29
Advances in biomaterials for the treatment of retinoblastoma
Farhat, W., Yeung, V., Ross, A., Kahale, F., Boychev, N., Kuang, L., Chen, L., & Ciolino, J. B. (2022) · Biomaterials Science · doi:10.1039/d2bm01005d · Cited by 29
Taketani, Y., Usui, T., Toyono, T., Shima, N., Yokoo, S., Kimakura, M., Yamagami, S., Ohno, S., Onodera, R., Tahara, K., et al. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.1 · Cited by 28
Isiegas, C., Marinich-Madzarevich, J. A., Marchena, M., Ruiz, J. M., Cano, M. J., de la Villa, P., Hernández‐Sánchez, C., de la Rosa, E. J., & de Pablo, F. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19300 · Cited by 28
Lai, K., Li, Y., Gong, Y., Li, L., Huang, C., Xu, F., Zhong, X., & Jin, C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110737 · Cited by 28
Kakkar, S., Singh, M., Karuppayil, S. M., Raut, J. S., Giansanti, F., Papucci, L., Schiavone, N., Nag, T. C., Gao, N., Yu, F. X., et al. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2020.1871483 · Cited by 28
Alanazi, J. S., Alqahtani, F. Y., Aleanizy, F. S., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020243 · Cited by 28
Rebaudioside A/TPGS mixed nanomicelles as promising nanocarriers for nimodipine ocular delivery
Li, X., Fang, J., Xin, M., Li, Q., Wang, J., Yang, H., & Wu, X. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00834-0 · Cited by 27
Pimecrolimus micelle exhibits excellent therapeutic effect for keratoconjunctivitis sicca
Yingfang, F., Zhuang, B., Wang, C., Xu, X., Xu, W., & Lv, Z. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2015.11.059 · Cited by 27
Sun, D., Sun, W., Gao, S., Wei, C., Naderi, A., Schilb, A. L., Scheidt, J. H., Lee, S. J., Kern, T. S., Palczewski, K., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.010 · Cited by 27
Ding, Y., Chow, S. H., Chen, J., Brun, A. P. L., Wu, C., Duff, A. P., Wang, Y., Song, J., Wang, J.-H., Wong, V. H. Y., et al. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.043 · Cited by 27
Zhang, Y., Yu, Y., Li, G., Zhang, X., Wu, Z., & Lin, L. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c00139 · Cited by 27
Santonocito, M., Zappulla, C., Viola, S., Rosa, L. R. L., Solfato, E., Abbate, I., Tarallo, V., Apicella, I., Platania, C. B. M., Maugeri, G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094404 · Cited by 27
Zhong, Y., Wang, K., Zhang, Y., Yin, Q., Li, S., Wang, J., Zhang, X., Han, H., & Yao, K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.753879 · Cited by 27
Self-citationLin, X., Yu, X., Chen, X., Sheng, S., Wang, J., Wang, B., & Xu, W. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.791954 · Cited by 27
Li, Q., Qian, X., Li, H. Y., Lai, K. L., Gao, Q., & Lee, W. Y. T. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120226 · Cited by 26
Wang, J., Xi, Y., Liu, Y., Wang, Z., & Zhang, Q. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13068 · Cited by 26
Prolonged prevention of retinal degeneration with retinylamine loaded nanoparticles
Puntel, A., Maeda, A., Golczak, M., Gao, S.-Q., Yu, G.-P., Palczewski, K., & Lu, Z. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.019 · Cited by 26
Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation
Ratay, M. L., Bellotti, E., Gottardi, R., & Little, S. R. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700733 · Cited by 26
Xu, J., Chen, P., Zhao, G., Wei, S., Li, Q., Guo, C., Cao, Q., Wu, X., & Di, G. (2022) · Current Eye Research · doi:10.1080/02713683.2021.2022163 · Cited by 26
Self-citationProtein and polypeptide mediated delivery to the eye
Attia, S. A., & MacKay, J. A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114441 · Cited by 26
Zhang, X., Bohner, A. D., Bhuvanagiri, S., Uehara, H., Upadhyay, A. K., Emerson, L. L., Bondalapati, S., Muddana, S. K., Fang, D., Li, M., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.01.014 · Cited by 23
Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Vincent, M. P., Stack, T., Vahabikashi, A., Li, G., Perkumas, K. M., Ren, R., Gong, H., Stamer, W. D., Johnson, M., & Scott, E. A. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c09294 · Cited by 23
Srinivasarao, D. A., Reddy, S. S., Reddy, G. B., & Katti, D. S. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121045 · Cited by 23
da Silva, F. R., Silva, R. O., Oliveira, H. M. D. C., Dourado, L. F. N., da Costa, B. L., Lima, B. S., Santos, N. G. L., Repeke, C. E. P., Menezes, G. B., Araújo, A. A. D. S., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110391 · Cited by 22
Li, Q., Wu, X., Xin, S., Wu, X., & Lan, J. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.106020 · Cited by 22
Lorenzo‐Soler, L., Praphanwittaya, P., Ólafsdóttir, Ó. B., Kristinsdottir, I. M., Ásgrímsdóttir, G. M., Loftsson, Þ., & Stefánsson, E. (2022) · Acta Ophthalmologica · doi:10.1111/aos.15101 · Cited by 22
Gao, S., Kahremany, S., Zhang, J., Jastrzębska, B., Querubin, J. R., Petersen‐Jones, S. M., & Palczewski, K. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.111294 · Cited by 21
Fernandes, A. R., Bonilla-Vidal, L., Sánchez‐López, E., dos Santos, T., Granja, P. L., Silva, A. M., García, M. L., & Souto, E. B. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121938 · Cited by 21
Retinal neuroprotection by controlled release of a VCP inhibitor from self-assembled nanoparticles
Sen, M., Al-Amin, M., Kicková, E., Sadeghi, A., Puranen, J., Urtti, A. O., Caliceti, P., Salmaso, S., Arango‐González, B., & Ueffing, M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.09.039 · Cited by 20
Winkler, J., Wirbelauer, C., Frank, V., & Laqua, H. (2001) · Experimental Eye Research · doi:10.1006/exer.2000.0952 · Cited by 19
New Drug Delivery for Corneal Neovascularization Using Polyion Complex Micelles
Usui, T., Sugisaki, K., Amano, S., Jang, W., Nishiyama, N., & Kataoka, K. (2005) · Cornea · doi:10.1097/01.ico.0000178738.29459.59 · Cited by 19
Lee, T. W.-Y., & Robinson, J. R. (2009) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2008.0010 · Cited by 19
Han, H., Son, S., Son, S., Kim, N., Yhee, J. Y., Lee, J. H., Choi, J., Joo, C.-K., Lee, H., Lee, D., et al. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201600051 · Cited by 19
Self-citationBehroozi, F., Abdkhodaie, M.-J., Abandansari, H. S., Satarian, L., Ashtiani, M. K., Jaafari, M. R., & Baharvand, H. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.05.056 · Cited by 18
Anti-angiogenesis by dual action of R5K peptide conjugated itraconazole nanoparticles
Chittasupho, C., Kengtrong, K., Chalermnithiwong, S., & Sarisuta, N. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-019-1568-8 · Cited by 18
Tawfik, M., Zhang, X., Grigartzik, L., Heiduschka, P., Hintz, W., Henrich‐Noack, P., van Wachem, B., & Sabel, B. A. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.313068 · Cited by 18
Guo, H., Ju, Y., Choi, M., Edman, M. C., Louie, S. G., Hamm‐Alvarez, S. F., & MacKay, J. A. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121441 · Cited by 18
Yogaraj, V., Gautham, G., Akshata, C., Manikandan, R., Murugan, E., & Arumugam, M. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101785 · Cited by 17
Dry Eye Treatment with Topical Cyclosporine 0.1% in Chondroitin Sulfate Ophthalmic Emulsion
Matossian, C., Trattler, W., & Loh, J. (2021) · Clinical ophthalmology · doi:10.2147/opth.s308088 · Cited by 17
Chau, Y., Suen, W. L. L., Tse, H. Y., & Wong, H. S. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.01.016 · Cited by 16
Jeong, H., Park, S., Park, K., Kim, M., & Hong, J. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01137 · Cited by 16
Liu, J., Luo, L., Xu, F., Li, G., Chen, J., Teng, L., Li, Y., & Sun, F. (2020) · Molecules · doi:10.3390/molecules25214897 · Cited by 16
Navarro‐Partida, J., Altamirano-Vallejo, J. C., Lopez-Naranjo, E. J., la Rosa, A. G., Manzano-Ramírez, A., Apátiga-Castro, L. M., Armendáriz‐Borunda, J., & Santos, A. (2020) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2019.0143 · Cited by 15
Yang, Z., Wu, J., Wu, K., Luo, J., Li, C., Zhang, J., Zhao, M., Mei, T., Liu, X., Shang, B., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00600 · Cited by 15
Liu, Z., Xu, J., Li, H., Shu, J., Su, G., Zhou, C., & Yang, P. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s349360 · Cited by 14
Self-citationDate, A. A., Kates, M. R., Yoshida, T., Babu, T., Afzal, U., Kanvinde, P. P., Baras, A. S., Anders, N. M., He, P., Rudek, M. A., et al. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00870-w · Cited by 13
Navarro‐Partida, J., Altamirano-Vallejo, J. C., Aceves-Franco, L. A., González-Cortés, J. H., Mota, S. E. H.-D., García‐Aguirre, G., Azuara-Galindo, C. D., Castro‐Castañeda, C. R., Armendáriz‐Borunda, J., & Santos, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091491 · Cited by 13
A Bioadhesive Nanoplatform Enhances the Permeation of Drugs Used to Treat Diabetic Macular Edema
Zhang, Y., Yu, Y., Li, G., Meng, H., Zhang, X., Dong, L., Wu, Z., & Lin, L. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00080 · Cited by 7
KPI-121 1% for Pain and Inflammation in Ocular Surgery
Beckman, K. A., Katz, J. A., Majmudar, P. A., Rips, A. G., Vaidya, N. S., & Rostov, A. T. (2021) · Pain Management · doi:10.2217/pmt-2021-0023 · Cited by 7
Kim, E. S., Lee, M. S., Jeong, H., Lim, S. Y., Kim, D., Kim, D., Jung, J., Lyu, S., Cho, H. J., Kim, D., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101548 · Cited by 6
Cited by
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects
Li, S., Chen, L., & Fu, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01992-2 · Cited by 277
Self-citationAn insight on ophthalmic drug delivery systems: focus on polymeric biomaterials-based carriers
Shafiq, M., Rafique, M., Cui, Y., Pan, L., Do, C.-W., & Ho, E. A. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.08.041 · Cited by 67
Metadata
- Authors
- Han, H., Li, S., Xu, M., Zhong, Y., Fan, W., Xu, J., Zhou, T., Ji, J., Ye, J., & Yao, K.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2023-05
- Volume
- 196
- Pages
- 114770
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W4323350844
- Cited by
- 322
- References
- 385
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.